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Abstract
BACKGROUND
Magnetic resonance enterography (MRE) and wireless capsule endoscopy (WCE)
are equally accepted modalities for noninvasive screening of small bowel
involvement (SBI) in children with Crohn’s disease (CD) and indeterminate
colitis (IC) albeit there is a paucity of data comparing the two and thereby
guiding the clinician in selecting the ideal diagnostic approach. Therefore, the
goal of this study is to provide additional evidence for capsule endoscopy role in
the evaluation of established Crohn’s disease exacerbation compared to MRE in
relation to Pediatric Crohn's Disease Activity Index (PCDAI), and histological
indices.
AIM
To prospectively compare the findings of MRE and WCE and their agreement
with PCDAI or histology in children with CD or IC.
METHODS
Consecutive patients diagnosed with CD and IC were screened for inclusion.
After informed consent, patient’s demographic and clinical data was abstracted.
The current pediatric disease activity index (PCDAI) and endoscopic findings
were included. Patients underwent MRE and WCE including preprocedural
patency capsule within a maximum of 7 d of each other. Pathological presence of
active small bowel disease in ileal and duodenal biopsies were collected if the
endoscopy was performed within 2 mo of the WCE study. Patients who failed to
pass the PC were excluded from the study. WCE was read by two different
experienced gastroenterologists (Attard TM and Colombo JM) blinded to each
other's findings and to the findings on MRE (Mardis NJ). Agreement between
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CONSORT 2010 statement: Not

WCE reviewers, WCE and MRE findings and concordance between positive
PCDAI and SBI based on MRE compared with WCE was computed.
RESULTS
Forty-five patients were included in the study, 18 withdrew and 27 (20 males and
20 CD), mean age (standard deviation) 13.46 (2.4) years, completed the study
protocol. There were no instances of capsule retention. Concordance between
gastroenterologist reviewers was excellent for the diagnosis of small intestinal
CD with good correlation between the two Lewis scores (r = 0.875, P < 0.001).
Concordance between WCE and MRE was poor (69%). In CD patients, when both
MRE and WCE were compared using PCDAI > 10 as the standard reference
reflecting active small intestinal CD, the sensitivity of MRE and WCE were 100%
and 83% respectively and the specificity of MRE and WCE were 57.14% and
78.6%, respectively. If the histology in ileum or/and duodenum was used as the
reference for active small bowel involvement, WCE had a higher specificity as
compared to MRE (83.3% vs 50%). In patients with Crohn’s disease, those with a
positive PCDAI (> 10) were more likely to have a positive WCE as compared to
those with a negative PCDAI (83% vs 21%; P = 0.018).
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CONCLUSION
We suggest that MRE and WCE have a complementary role in the assessment of
SBI in CD. WCE detected SBI with a much higher specificity while MRE had a
higher sensitivity.
Key words: Crohn’s disease; Wireless capsule endoscopy; Inflammatory bowel disease;
Magnetic resonance enterography; Small bowel involvement; Small bowel disease;
Indeterminate colitis; Pediatric; Children
©The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.
Core tip: There are a number of prospective adult studies and few in pediatrics
comparing magnetic resonance imaging (MRE) to wireless capsule endoscopy (WCE) in
identifying small bowel (SB) Crohn’s disease (CD) that showed no significant difference
in the diagnostic yield and accuracy of MRE and WCE in established non-stricturing
crohns disease or suspected and established CD together. This study is the first
prospective study in children with established inflammatory bowel disease in the United
States assessing and comparing the roles of MRE and WCE in identifying SB disease
involvement in relation to clinical and histological indices.

Citation: Hijaz NM, Attard TM, Colombo JM, Mardis NJ, Friesen CA. Comparison of the use
of wireless capsule endoscopy with magnetic resonance enterography in children with
inflammatory bowel disease. World J Gastroenterol 2019; 25(28): 3808-3822
URL: https://www.wjgnet.com/1007-9327/full/v25/i28/3808.htm
DOI: https://dx.doi.org/10.3748/wjg.v25.i28.3808

INTRODUCTION
Crohn’s disease (CD) is a chronic inflammatory disorder primarily involving the
gastrointestinal tract. Although any part of the gastrointestinal tract may be involved,
proximal small intestinal involvement is more common in pediatric patients than in
adult patients with a prevalence of up to 20% [1] . The effects of small intestinal
involvement in CD are variable and may include obscure abdominal pain, nutritional
sequelae resulting in growth delay, iron deficiency anemia, stricture formation, and
potentially small bowel obstruction[1,2]. Proximal small bowel (SB) involvement in CD
is associated with a more aggressive disease course and an increased need for
surgery[3,4]. Therefore, accurate determination of SB involvement (SBI) in pediatric CD
is crucial for optimal patient management[3,4].
Current clinical guidelines include suggested modalities to identify SBI and
determine management plans [5] . Available options include small bowel series,
computed tomography enterography (CTE), small bowel wireless capsule endoscopy
(WCE), gadolinium enhanced magnetic resonance imaging (GAD MRI), and small
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bowel contrast enhanced ultrasound (US). The choice of modality is largely
determined by available resources, radiation exposure risk, physician and
institutional preferences. MRE and contrast enhanced US are radiation free, while
other radiologic modalities entail a risk of radiation exposure[6]. WCE may entail a risk
of capsule retention. The risk of capsule retention resulting in obstruction is increased
in the context of stricturing or fistulizing disease in CD and has been estimated at
2.6% [7] but may be greatly mitigated by patency capsule screening [8] . Magnetic
resonance enterography (MRE) and small intestine contrast ultrasound (SICUS) have
diagnostic effectiveness comparable to other radiological modalities for evaluation of
CD patients[1,2,9]. However, both studies have their own limitations. MRE is limited by
expense, the availability of the requisite equipment and software, variable expertise in
interpretation of the findings, and (potentially) the need for sedation in pediatric
population. SICUS is similarly affected by being operator dependent with the
requisite need of accumulated expertise and heightened need for cooperation during
the study that can limit its use in pediatric populations[10].
Other diagnostic modalities have been evaluated in comparison to WCE in several
pediatric and adult inflammatory bowel disease (IBD) studies. Table 1 summarizes
the adult and pediatric studies comparing different modalities to WCE. The studies
conducted in children with IBD were mostly retrospective and aimed at evaluating
the role of MRE and WCE for detection of SB disease. They concluded that MRE and
WCE were comparable with similar sensitivities[11]. Only three prospective studies (all
European) in pediatric IBD have compared WCE and MRE modalities in identifying
SB disease involvement. Two were studies in established CD[9,12] and one in suspected
CD[13] and again, they suggested that the tests appear complementary for detection of
active CD. The current study is the first prospective study in children with established
IBD in the United States assessing the roles of MRE and WCE in identifying SB
disease involvement in IBD. This study provides evidence for capsule endoscopy role
in the evaluation of established disease exacerbation in patients with IBD in relation to
MRE.
The primary goals of this study are to prospectively compare the diagnostic yield,
concordance rate, sensitivity and specificity between MRE and WCE findings and
their agreement with the Pediatric Crohn's Disease Activity Index (PCDAI) or with
histological small bowel involvement in children with known IBD; CD or IC.
Secondary goals are to assess the performance of each of the modalities (MRE, WCE
and PCDAI) in relation to each other in order predict the results of the compared tests
and to assess the correlation between Lewis capsule endoscopy score and PCDAI.

MATERIALS AND METHODS
Patient selection
This study was a prospective single blinded comparison study of a cohort of pediatric
patients with established indeterminate colitis (IC) or CD at a tertiary referral
pediatric IBD center. The diagnosis of CD was confirmed by using widely validated
clinical, endoscopic, and histological criteria. The study was approved by the ethics
committee of the hospital IRB #13080263 and written informed assent/consent was
obtained from all children and their parents. Study participants were enrolled if they
were 4-18 years of age inclusive with an established diagnosis of IC or CD and
planned to have an MRE as part of standard of care. Patients were excluded if they
had recent intestinal tract surgery, resection involving small bowel, gastrointestinal
obstruction or ileus, swallowing disorders, esophageal stricture, nonsteroidal antiinflammatory drugs or prokinetic medication use in the 4 wk prior to enrollment,
inability to swallow the capsule, or if they had an electro-medical device or
pacemaker. Demographic and clinical data were recorded including subject
demographics, medical and surgical history, imaging results, initial disease
presentation, and patient current clinical status which was used to calculate the
PCDAI. The PCDAI score is considered positive (active disease) if ≥ 10 and negative
(inactive disease) if < 10 (Table 2).

Patency capsule
All patients swallowed a patency capsule (PC; size 11 mm × 26 mm) to assess small
bowel patency. All patients with confirmed passage of PC in the first 40 h underwent
WCE (Pillcam™ SB Capsule, Given Imaging Ltd, Israel 11 mm × 26 mm) within 1 wk
of completion of MRE. Patients excluded from the study if they failed to swallow or
pass the PC. WCE was read by two different experienced gastroenterologists, each
with > 10 years of experience (Attard TM and Colombo JM) blinded to each other's
findings and to the findings on MRE (Mardis NJ). The PCDAI was recorded from the
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Table 1 Summery of studies comparing imaging modalities to capsule endoscopy
Modalities compared
Results
to CE

Author /year / type

Country

Age group/ total No.

Patient population

Albert 2005[14]

Germany

Adults/52

Established and
suspected CD

MRE

Diagnostic yield of WCE
is superior to MRE ( +ve
MRE 32/52 vs +ve WCE
25/27)

Golder 2006
prospective[15]

Germany

Adults/16

Established CD

MRE

Diagnostic yield of WCE
is similar to that of MRE
( +ve MRE 9/15 vs +ve
WCE 11/15), but the
WCE is superior in
detecting proximal SB
disease

Tillack 2008
prospective[16]

Germany

Adults/19

Established CD

MRE

Diagnostic yield of WCE
is similar to that of MRE
(+ve MRE 18/19 vs +ve
WCE 18/19) but the
WCE is superior in
detecting proximal SB
disease

Dionisio 2010
prospective

Europe, Canada, Israel
and United States

All ages/ 428

Established and
suspected CD

CTE and SBFT and MRE Diagnostic yield of WCE
is superior to that of
CTE and SBR in
suspected CD but it is
similar to MRE in
suspected and
established CD

Crook 2009
prospective[18]

Switzerland

Adults/5

Suspected CD

MRE

Diagnostic yield of WCE
is similar to that of MRE
and complementary to
each other

Bocker 2010
prospective[19]

Germany

Adults/21

Established and
suspected CD

MRE

Diagnostic yield of WCE
is similar to that of MRE
( +ve MRE 6/21 vs +ve
WCE 9/21) but the WCE
is superior in detecting
proximal SB disease

Jensen 2011
prospective[20]

Denmark

Adults/93

Established and
suspected CD

MRE

Diagnostic yield of WCE
is similar to that of
MRE( +ve MRE 24/80 vs
+ve WCE 22/80) but the
WCE is superior in
detecting proximal SB
disease

Wiarda 2011
prospective[21]

The Netherlands

Adults/38

Established and
suspected CD

MRE

Diagnostic yield of WCE
is similar that of MRE (
+ve MRE 16/38 vs +ve
WCE 6/25)

Kopylov 2015
prospective[22]

Israel

Adults/77

Established CD

MRE

Diagnostic yield of WCE
is similar to that of MRE
( +ve MRE 40/52 vs +ve
WCE 42/52) but the
WCE is superior in
detecting proximal SB
disease

Gonzalez Suarez 2017
retrospective[23]

Spain

Adults/47

Established and
suspected CD

MRE

WCE is superior to MRE
in detection of small
bowel lesions mainly
proximal(+ve WCE
36/47 vs +ve MRE
21/47)

Di Nardo 2010
prospective[24]

Italy

Peds/117

Established and
suspected CD

MRI and SICUS

reclassifying
indeterminate colitis
(IC) into CD (60%),
detection of CD lesions
in known CD (41%) and
establishing new
diagnosis in suspected
CD (50%)

Metanalysis[17]
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Casciani 2011
prospective[13]

Italy

Peds/60

suspected CD

MRE

Gralnek 2012
prospective[25]

Israel

Peds /18

Established and
suspected CD

No studies compared

Kovanlikaya 2013[11]
retrospective

United States

Peds/23

Established and
suspected CD

MRE

Sensitivity of MRE 75%
was similar to WCE
77.8%

Aloi 2015 prospective[9] Italy

Peds/25

Established and
suspected CD

MRE and SICUS

Diagnostic yield of WCE
is similar to that of MRE
and SICUS ( +ve MRE
15/25 vs +ve SICUS
16/25 vs +ve WCE
16/25) but the WCE is
superior in detecting
proximal SB disease

Oliva 2016
prospective[12]

Peds/38

Established CD

MRE and SICUS

Diagnostic yield of WCE
is similar to that of MRE
and SICUS ( +ve MRE
19/38 vs +ve WCE
19/38 vs +ve SICUS
21/38) but the CCE is
superior in detecting
proximal SB disease

Italy

Diagnostic yield of WCE
is similar to that of MRE
( +ve MRE 19/37 vs +ve
WCE 10/60)

WCE: Wireless capsule endoscopy; CCE: Colon capsule endoscopy; SBR: Small bowel radiography; CTE: Computed tomography enterography; MRE:
Magnetic resonance enterography; SICUS: Small intestinal contrast ultrasonography; CD: Crohn’s disease; IC: Indeterminate colitis; Peds: Pediatric; +ve:
Positive.

most recent medical chart and laboratory data. Blood samples for hemoglobin and
hematocrit, erythrocyte sedimentation rate, C-reactive protein (CRP), and albumin
were collected within 7 d if these labs were not obtained in the last 2 wk prior to
WCE.

MRE
MRE examinations were performed as a standard of care by using a whole body
magnetic resonance imaging unit (Children’s Mercy Hospital, Kansas City, MO,
United States) with an 8-channel abdominal phased-array coil. A benefiber dissolved
in liquid with weight-based dosing was used as the intraluminal oral contrast agent.
Intravenous contrast was administered to reduce SB peristalsis and to prolong
luminal distention. Axial and coronal T1 weighted images with fat suppression were
performed. When the distention quality was inadequate, images were reobtained 30
minutes after the ingestion of a more appropriate dose for age of fiber water solution.
Axial T2, axial diffusion and coronal true cine images were obtained.
One radiologist retrospectively reviewed the MRE for all subjects to provide a
consistent assessment of the extent of SB activity for each subject. Patients with a MRE
score of >3 were considered to have positive MRE study[20]. The score was modified in
this study to exclude counting colonic segment involvement in the overall radiological
score (maximum score is 13). Evaluated findings included SB wall thickness (0-3 mm
or 3-6 mm, > 6mm), SB wall enhancement after intravenous contrast media (none,
mild or severe), mucosal and serosal enhancement suggestive of mesenteric fatty
infiltration, strictures (defined as luminal narrowing to be less than 10 mm), increased
mesenteric vascularity close to the inflamed bowel loop, mesenteric
lymphadenopathy, the presence of fistula, stricture or abscess and the number of SB
segments involved (duodenal, jejunal and ileal)[9]. MRE score used is provided in supplemental material.

WCE
The capsule images were independently interpreted by two gastroenterologists with >
10 years of experience in capsule studies. To optimize the visualization of the jejunum
and ileum of the CE, after an overnight fast, patients ingested Polyethylene Glycol
3350 PEG before they swallowed the capsule (PEG doses adjusted based on age: 34 g
in 480 mL clear liquid if age of the subject was < 5 year, 51 g in 720 mL if 5-10 years, 68
g in 960 mL if >10 years). The CE used in this study was the PillCam™ SB video
capsule (Given Imaging, Medtronics Ltd, Yokneam, Israel). It measures 11 mm × 26
mm and it weighs less than 4 g. This capsule was ingested orally in all patients except
for one patient who was scheduled to have endoscopy on the same day, so the capsule
was deployed by esophagogastroduodenoscopy. Capsule retention is defined as a
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Table 2 Highlights baseline characteristics of patient’s demographics and clinical and
endoscopic descriptions
All patients CD and IC n = 27

CD n = 20

Age at diagnosis year

13.46 (2.40)

13.48 (2.02)

Male %

74%

75%

Biological alone or combination therapy

12/27 (44.4%)

11/20 (55%)

Immune modulators with no biologic combination

8/27 (30%)

5/20 (25%)

5 ASA +- steroids

4/27 (15%)

3/20 (15%)

Steroids alone

2/27 (7%)

0/20 (0%)

Antibiotic alone

1/27 (4%)

1/20 (5%)

Inflammatory

93%

93%

Stricturing

7%

7%

Duration of disease year

1.7 (2.32)

2.1 (2.57)

BMI percentile

57 (32.9)

58.18 (35.83)

PCDAI

10.2 (12.5)

9.8 (11.6)

SB transit time min

233 (115.4)

241(184.99)

Days between MRE and WCE days

4.19 (1.88)

4 (1.90)

Medications ratio (%)

Phenotype%

Baseline characteristics of all patients expressed in mean (SD) and the ratio (percentage). CD Crohn’s disease,
IC indeterminate colitis, ASA amino salicylate, SB small bowel, BMI body mass index, MRE magnetic
resonance enterography, PCDAI pediatric Crohn’s disease activity index WCE wireless capsule endoscopy.

failure of the passage of the capsule from the gastrointestinal tract for ≥ 2 wk[20]. The
examination was incomplete if the capsule did not reach the cecum by the end of the
study. Images were considered as negative (or inactive) if no abnormalities were seen
and as positive (or active) if clear abnormalities of the SB mucosa (ulcerations > 3,
erosions, polyps, vascular lesions, and bleeding lesions were seen). White lesions
within a crater with surrounding erythema were considered ulcers, whereas small
superficial white lesions, even with surrounding erythema, were considered
erosions[24]. If no abnormalities or non-specific findings (such as erythematous spots or
mucosal damage) were seen, the examination was considered non-specific or normal.
All capsule readers were blinded to each other’s findings or radiological MRE images
but were aware of the patient’s medical history and laboratory testing. In addition,
evaluators used the capsule endoscopy data collection form including the Lewis
scoring system that is automatically calculated and included in the RAPID™
software[26]. The Lewis score is a WCE ranking of inflammatory activity into three
levels based on erythema, stenosis, edema and erosions in small intestinal tertiles: (1)
No disease or clinically insignificant disease (LS < 135); (2) Mild disease (135 ≤ LS ≤
790); and (3) Moderate or severe disease (LS > 790). Any WCE with Lewis score more
than 135 is considered positive[26].

Histological findings
A subgroup of 15 of the 27 patients had pathology specimens available for review
within 2 mo of the WCE study [mean 3.9 wk, standard deviation (SD) = 2.58].
Pathology specimens from the terminal ileum and duodenum were evaluated as they
are considered the accepted reference standard to determine active CD in the SB.
Histology findings were considered positive if the subject had final impression of
chronic active ileitis or duodenitis or if there was a description of at least one of the
chronic changes (architectural changes, increase in lamina propria mononuclear cells
and lamina propria PMNs) together with at least one of activity histology findings
(epithelial damage, intraepithelial PMNs in surface epithelium, cryptitis, crypt
abscess, erosions/ulcers, or granulomas) in either ileal or duodenal biopsies. This is
based on the histological remission definition proposed by a systemic review with
absence of neutrophils in crypt and lamina propria, basal and lamina propria plasma
cells and eosinophils[27] and the in the diagnosis guidelines for CD[2]. The histology
grading used is provided in the supplemental material.

Statistical analysis
Descriptive data was expressed as the mean [± standard deviation (SD)] for the
continuous variables. Categorical data were expressed as frequencies and per-
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centages. A Chi square with the Fisher correction was used to evaluate the differences
for categorical variables when appropriate. Statistical significance is expressed as P <
0.05
For each of the 2 methods evaluated (MRE and WCE), sensitivity, specificity,
negative predictive value, positive predictive value, and accuracy were determined by
the available PCDAI and histological findings from the terminal ileum and
duodenum. The Fisher exact test was used to evaluate the performance of each
method in relation to another. Exact binomial 95% confidence intervals were also
reported. The sample size of 34 children was estimated as having an 80% power to
detect 23% difference in IBD small intestinal MRE findings and WCE detection rate.
This size was estimated based on our previous retrospective study[24].
The Pearson correlation coefficient was utilized to assess agreement between Lewis
capsule endoscopy score and PCDAI. All P values were 2 sided with statistical
significance evaluated as statistical significance P < 0.05. All analyses were performed
in SPSS Version 19.0 (SPSS Inc., Chicago, IL, United States).

RESULTS
Forty-five subjects with the diagnosis of CD or IC were enrolled. Twenty-seven
patients completed all of the procedures of the study, 20 with CD (74%) and 7 with IC
(26%). Eighteen patients were excluded because of inability to swallow PC (4/18),
failure to pass PC (3/18) or failure to follow or complete study procedures (3/18),
screen failure (1/18) or elective withdrawal from study (7/18).
Concordance between gastroenterologist reviewers for the diagnosis of small
intestinal CD was excellent with strong correlation between the two Lewis score (r =
0.875, P < 0.001). The studies were incomplete in 3 patients. Two of these
demonstrated active CD and one was negative. The patient with a negative
incomplete study was excluded. There were no capsule retentions in any of the
studies. All capsules passed within 2 wk of the WCE and no surgical interventions
were needed. The mean small intestinal transit time was comparable (260.2 min, 218.2
min, P = NS) for WCE positive and negative studies respectively. The Pearson
correlation coefficient between average Lewis score between both reviewers and
PCDAI is very poor (r = 0.12, P = NS). Agreement rates for positive WCE, MRE, and
PCDAI for the total subject group is shown in Figure 1. Agreement rates for positive
WCE, MRE, and SB Histology for the 14 patients in which the histology was available
are shown in Figure 2.
The concordance rate between WCE and MRE was poor (69%) in collectively
matched positive and matched negative subjects. The concordance rate between MRE
and WCE is shown in Figure 3 in all subject patients (CD and IC) and in Figure 4 in
CD only patients.
Histology was available for fifteen patients within 2 mo of the WCE study (mean
3.9 wk and SD = 2.58) and 8 of them demonstrated active CD histology in the ileum
and one in the duodenum. For one of the patients who has diagnosis of IC with
positive histology, the WCE interpretation was discrepant between reviewers and this
patient was dropped from the analysis leaving 14 patients analyzed in the histology
comparison and 26 total patients. In CD patients, when both MRE and WCE were
compared using PCDAI > 10 as the standard reference reflecting active small
intestinal CD, the sensitivity of MRE and WCE were 100% and 83% respectively and
the specificity of MRE and WCE were 57.14% and 78.6%, respectively. If the histology
in ileum or/and duodenum was used as the reference for active small bowel
involvement, WCE had a higher specificity as compared to MRE (83.3% vs 50%). See
Table 3.
When all IBD patients were taken collectively, there was no statistically significant
relationship between the performance of either MRE or WCE with PCDAI or with
each other. However, in patients with CD, those with a positive PCDAI (> 10) were
more likely to have a positive WCE as compared to those with a negative PCDAI (83%
vs 21%; P = 0.018). There was no significant difference in the frequency of a positive
MRE comparing those with and without a positive PCDAI. See Table 4.

DISCUSSION
There are several modalities available to screen for small intestinal involvement in
IBD[1]. However, there is no consensus on a gold standard and it remains controversial
whether one of the available examinations is adequate for assessment of SB Crohn’s
alone or if it should be used in conjunction with other investigative modalities.
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Figure 1

Figure 1 Concordance rate of positive small bowel involvement in the pediatric Crohn’s disease activity
index, positive magnetic resonance imaging, and wireless capsule endoscopy modalities in all patients n =
26. PCDAI: Pediatric Crohn’s disease Activity Index; MRE: Magnetic resonance enterography; WCE: Wireless
capsule endoscopy.

There are several prospective adult studies comparing MRE to WCE in identifying
SB Crohn’s which conclude that there is no significant difference in the diagnostic
yield and accuracy of MRE and WCE in established non-stricturing CD [15,16,28] or
suspected and established CD together[19,20,21]. However, proximal small bowel lesions
were more often detected using WCE rather than MRE [16,19,20,21] . Moreover, other
prospective studies have shown superiority for WCE[14,23].
The published pediatric studies are far more limited especially ones utilizing MRE
as radiological modalities[9,12,13] and they have evaluated heterogeneous groups of IBD
patients[9,13,24]. Because there is no consensus on the best screening tool for SB in CD,
most of the previous studies evaluated the performance of WCE or imaging studies as
the measure of diagnostic yield. It is noteworthy that this approach is suboptimal and
simply suggests that a test can detect abnormalities rather than confirming its
significance.
Our study is one of the first prospective studies in the United States to compare
clinical, radiological and histological measures to WCE in assessing SB activity in
pediatric IBD specifically CD and indeterminate colitis. The primary focus was on
established Crohn’s disease and did not include heterogeneous populations with
suspected IBD[9,24]. Our study demonstrates excellent inter-observer agreement in the
interpretation of WCE, suggesting WCE is highly reproducible.
Because of the absence of a standard criteria for confirming proximal SB CD
activity that is feasible and less invasive in children, this study used two different
references to compare MRE with WCE. The first was the PCDAI as a global clinical
standard for overall disease activity and the second was pathological findings in the
ileum and duodenum as histological standards for SBI. We have used PCDAI because
the evidence suggested its moderate correlation with pediatric CD activity and
endoscopic scores[29,30]. PCDAI < 10 is the standard definition of inactive CD that is
used in clinical trials for clinical response to medical therapies[29,30]. Pediatric onset CD
runs a more aggressive active disease course, including more extensive disease
location, more upper GI involvement and increased need for more aggressive medical
therapy, in pediatric studies[31-33]. This is also replicated in adult studies; proximal
small bowel involvement should be considered as high risk in terms of CD-related
surgery[34-36]. In particular L4 (proximal SB not including TI) disease phenotype was
associated with stricturing disease, and significantly increased risk for multiple
surgeries[37,38]. Pediatric phenotypes of CD at the time of diagnosis showed 50.9%were
affected by CD proximal to the terminal ileum in United Kingdom[39]. In Europe,
isolated ileal disease (L1) is reported to be 16% in CD children, or proximal to
terminal ileal (L4) in 24% and esophagogastroduodenal (EGD) involvement in 30%[33].
If pediatric CD mostly runs an aggressive and extensive course involving small bowel
either in more than half of children, then using PCDAI can arguably be justified to
reflect active small bowel disease. However, this is still a limitation in this study
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Figure 2

Figure 2 Concordance rate of positive small bowel involvement in wireless capsule endoscopy, magnetic
resonance enterography and small bowel histology modalities in only patients with available histology n =
14. SB: Small bowel; WCE: Wireless capsule endoscopy; MRE: Magnetic resonance enterography.

because it does not exclude the possibility of bowel disease activity overall and it is
not validated to accurately reflect SBI compared to other invasive reliable standards.
Pediatric prospective studies used ileocolonoscopy as the reference standard for
identifying active CD in the terminal. Moreover, a consensus reference standard was
used to determine active CD in the proximal bowel[9,12]. This consensus is basically
made up of clinical expert opinion reviewing the results of available images, labs and
capsule endoscopy to decide jejunal and duodenal activity.
The current study showed near similar results for both references. However, there
was relatively poor agreement between WCE and MRE in sensitivity or specificity.
We found a higher sensitivity for MRE as compared to WCE with both standards.
While WCE was more specific than MRE in detecting SB disease, the two modalities
were comparable in test accuracy.
Our findings are consistent with previously reported pediatric studies which
suggest that MRE and WCE are comparable in accuracy for detecting SB disease[9,13]. In
contrast, Oliva and colleagues, in a study of established CD in children, demonstrated
slightly better accuracy of colon capsule endoscopy including SB images than MRE
and SICUS. [12] Our results are consistent with a recent systemic review by Giles
revealing a pooled sensitivity and specificity for MRE for detecting active SB CD of
84% and 97%, respectively, with endoscopy as the reference test[39]. However, the
specificity of MRE is much lower in our study at 50%-57%, likely attributed to a
smaller sample size.
MRE was found to be a sensitive and specific test with a decent diagnostic yield in
a systemic review published in 2013 [40] . The higher sensitivity of MRE may be
attributed to the low threshold being used in MRI scoring systems in few studies, the
inclusion of colonic activity in some of the studies or localization of SB segments
based on anatomic sectioning of the images[16,20]. Detection of proximal small bowel
inflammation in CD by MRE is challenging. Newer suggested scoring systems such as
MRI global score MEGS provide potential accurate evaluation of the SB and strongly
correlates with inflammation detected with fecal calprotectin and with pan-intestinal
inflammatory activity[41] but it is very time consuming and cumbersome limiting
practicality[42-44]. Moreover, terminal ileum MRI index of Activity (MaRIA) score has
been developed but it did not address perfectly the activity of the proximal SB
disease[42].
Our study has uniquely modified the score reported by Jensen and discounted
colonic involvement to accurately focus on scoring only small bowel findings in term
of enhancement, thickening, vascular, lymphatic or fatty mesenteric changes or
presence of SB complications (abscess, fistula, stricture) with same cut off > 3 to robust
SB MRI score. Whether this modified score has a clinical significance is yet to be
validated. This certainly suggests the need for standardizing MRI scoring, especially
in children. Until a validated score is universally accepted, the possibility of MRE
false positive results and the possibility of an overestimated positive yield MRE

WJG

https://www.wjgnet.com

3816

July 28, 2019

Volume 25

Issue 28

Hijaz NM et al. Capsule endoscopy in pediatric IBD
Figure 3

Figure 3 Concordance rate of magnetic resonance imaging and wireless capsule endoscopy in all patients.
WCE: Wireless capsule endoscopy; MRE: Magnetic resonance enterography; Pos: Positive; Neg: Negative.

should be taken into consideration.
In the current study, the specificity of WCE was higher than that of MRE (83% vs
50%) which contrasts with what has been reported in an established CD population
(94% in WCE vs 89% in MRE)[12]. Specificities of both WCE and MRE in the current
study were lower than that reported in pediatric patients with suspected or
established CD populations[12,13] and disagreed with Aloi et al[9] who found MRE to be
more specific than WCE (89% vs 72%, respectively). Our results differed with other
published studies likely because of the heterogeneity of populations used in their
analysis and possibly to our small sample size. Therefore, WCE may be suggested as a
unique confirmatory test in the assessment of mucosal disease activity. WCE has been
suggested as a secondary test if MRE is inconclusive [ 1 3 ] . Published expert
recommendations state that a negative capsule endoscopy in CD likely excludes the
presence of small bowel disease[45].
We were able to make comparison of the performance of pairs of tools (WCE, MRE
and PCDAI) with each other in patients with IBD (CD and IC) overall, and in patients
with CD only. The performance of one test was not able to predict the results of the
other test when WCE was compared to MRE or when MRE was compared toPCDAI.
However, in patients with CD, those with a positive PCDAI (> 10) were more likely to
have a positive WCE as compared to those with a negative PCDAI (P = 0.018). See
Table 4. This suggests that active disease defined with higher PCDAI score, will
increase the predictive ability of WCE to be positive and it supports the use of PCDAI
routinely in the assessment of SBI along with radiologic or endoscopic modalities.
This current study is limited by lack of an established reference or gold standard
that can be used to compare modalities that may result in a confirmation bias. We
therefore had to adopt several surrogate indices to determine if either diagnostic
modality correlated with SB disease. Additionally, the current study only partially
controls for timing of histology which might impact treatment measures that in turn
could impact study results from MRE, SBC or both. It also lacks the evaluation of
jejunal histology that can be affected in up to 20% of IBD patients. It is however
explained by the assumption that histological changes may lag longer than
endoscopic findings and microscopic inflammation persists in 25%-37% of cases of
endoscopically quiescent CD[27]. Finally, each subject acted as its own control as there
was no use of control group population.
Future studies should continue to integrate the use of WCE, low risk imaging
modalities and clinical parameters in defining of SBI in children with CD. It will be
useful to integrate a composite of these modalities in a practical validated scoring
measure that identify SBI in the least invasive approach.
Our study supports the use of the radiation free, less invasive and generally
tolerated imaging modalities of WCE and MRE with each having a favorable role in
the assessment of SBI in children with established CD. Although the unique ability of
the capsule to detect mucosal changes, and similar unique ability of MRE to detect
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Figure 4

Figure 4 Concordance rate of magnetic resonance imaging and wireless capsule endoscopy in Crohn’s
disease patients. WCE: Wireless capsule endoscopy; MRE: Magnetic resonance enterography; Pos: Positive; Neg:
Negative.

mural changes, there is still need for a standardized scoring system to describe the
specificity of these findings. WCE more accurately detected small bowel disease with
a much higher specificity while MRE had a higher sensitivity in pediatric IBD.
Patients with active CD (PCDAI > 10) were more likely to have a positive WCE as
compared to those with a negative PCDAI. Despite the disagreement between the two
modalities, accuracy was comparable between MRE and WCE suggesting that they
may have a complementary role in the assessment of small bowel disease.
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Table 3 Magnetic resonance imaging and wireless capsule endoscopy positivity predictive of small bowel involvement in reference
pediatric Crohn’s disease activity index > 10 and to histology
Reference standard is PCDAI > 10 indicate active CD

Reference standard is histology in ileum and duodenum

CD only patients (n = 20)

Histology available samples only (n = 14)

MRE

WCE

MRE

WCE

Value

95%CI

Value

95%CI

Value

95%CI

Value

95%CI

SEN

100%

54.07% to 100%

83.3%

35.88% to 99.58%

62.50%

24.49% to 91.48%

50.00%

15.70% to 84.30%

SP

57.14%

28.86% to 82.34%

78.6%

49.20% to 95.34%

50.00 %

11.81% to 88.19%

83.33 %

35.88% to 99.58%

PPV

50%

35.32% to 64.68%

62.5%

36.49% to 82.86%

62.50%

38.87% to 81.37%

80.00%

36.99% to 96.46%

NNP

100%

91.7%

64.29% to 98.53%

50.00 %

23.14% to 76.86%

55.56 %

36.43% to 73.17%

Accuracy

70%

80.0%

56.34% to 94.27%

57.14%

28.86-82.34%

64.29%

35.14% to 87.24%

45.72 to 88.11%

SEN: Sensitivity; SP: Specificity; PPN: Positive predictive value; NNP: Negative predictive value; MRE: Magnetic resonance enterography; PCDAI:
Pediatric Crohn’s Disease Activity Index; WCE: Wireless capsule endoscopy; CD: Crohn’s disease.

Table 4 Fischer exact performance of each diagnostic test compared to other modality or pediatric Crohn’s disease activity index
Studies compared

All patients (n = 26)

CD only (n = 20)

MRE and WCE

P = 0.428

P = 0.373

MRE and PCDAI

P = 0.395

P = 0.325

WCE and PCDAI

P =0.1892

P = 0.0181

MRE: Magnetic resonance enterography; PCDAI: Pediatric Crohn’s Disease Activity Index; WCE: Wireless capsule endoscopy; CD: Crohn’s disease.

ARTICLE HIGHLIGHTS
Research background
Magnetic resonance enterography (MRE) and wireless capsule endoscopy (WCE) are equally
accepted modalities for noninvasive screening of small bowel involvement (SBI) in children with
Crohn’s disease (CD) and indeterminate colitis (IC) and there is a paucity of data comparing the
two in children. Thereby guiding the clinician in selecting the ideal diagnostic approach. Many
prospective adult studies and few in pediatrics comparing MRE to WCE in identifying small
bowel (SB) CD showed no significant difference in the diagnostic yield and accuracy of MRE and
WCE in established non-stricturing CD or suspected and established CD together. The current
study is the first prospective study in children with established IBD in the United States
assessing the roles of MRE and WCE in identifying SB disease involvement in IBD. This study
provides evidence for capsule endoscopy role whether it is superior or complementary in the
evaluation of established disease exacerbation in patients with IBD in relation to MRE thereby
guiding the clinician in selecting the ideal diagnostic approach.

Research motivation
Therefore, the goal of this study is to provide additional evidence and guidance for capsule
endoscopy role in the evaluation of established CD exacerbation compared to MRE into relation
Pediatric Crohn's Disease Activity Index (PCDAI), and histological indices.

Research objectives
The primary goals of this study are to prospectively compare the diagnostic yield, concordance
rate, sensitivity and specificity between MRE and WCE findings and their agreement with the
PCDAI or with histological small bowel involvement in children with known IBD; CD or IC.
Secondary goals are to assess the performance of each of the modalities (MRE, WCE and PCDAI)
in relation to each other in order to predict the results of the compared tests and to assess the
correlation between Lewis capsule endoscopy score and PCDAI.

Research methods
Consecutive patients diagnosed with CD and IC were screened for inclusion. After informed
consent patient’s demographic and clinical data was abstracted. The current pediatric disease
activity index (PCDAI) and endoscopic findings were included. Patients underwent MRE and
WCE including preprocedural patency capsule within a maximum of 7 d of each other.
Pathological presence of active small bowel disease in ileal and duodenal biopsies were collected
if the endoscopy was performed within 2 mo of the WCE study. Patients who failed to pass the
PC were excluded from the study. WCE was read by two different experienced
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gastroenterologists (Attard TM and Colombo JM) blinded to each other's findings and to the
findings on MRE (Mardis NJ). Agreement between WCE reviewers, WCE and MRE findings and
concordance between positive PCDAI and SBI based on MRE compared with WCE was
computed.

Research results
In CD patients, when both MRE and WCE were compared using PCDAI > 10 as the standard
reference reflecting active small intestinal CD, the sensitivity of MRE is higher than WCE but
specificity of MRE were lower than WCE. If the histology in ileum or/and duodenum was used
as the reference for active small bowel involvement which is usually the most reliable reported
standard, WCE had a higher specificity as compared to MRE (83.3% vs 50%). Concordance
between WCE and MRE was poor (69%) whether both agreed positively or negatively. While
WCE was more specific than MRE in detecting SB disease, the two modalities were comparable
in test accuracy. Specificities of both WCE and MRE in the current study were lower than that
reported in pediatric patients with suspected or established CD populations. An active disease
defined with higher PCDAI score > 10, will increase the predictive ability of WCE to be positive
and it supports the use of PCDAI routinely in the assessment of SBI along with radiologic or
endoscopic modalities. The argument remains to be elucidated on what is the gold standard that
best identify the SBI in patients with IBD.

Research conclusions
Our study supports the use of the radiation free, less invasive and generally tolerated imaging
modalities of WCE and MRE with each having a favorable role in the assessment of SBI in
children with established CD. Although the unique ability of the capsule to detect mucosal
changes and similar unique ability of MRE to detect mural changes, there is still need for a
standardized scoring system to describe the specificity of these findings. WCE more accurately
detected small bowel disease with a much higher specificity while MRE had a higher sensitivity
in pediatric IBD. Patients with active CD (PCDAI > 10) were more likely to have a positive WCE
as compared to those with a negative PCDAI. Despite the disagreement between the two
modalities, accuracy was comparable between MRE and WCE suggesting that they may have a
complementary role in the assessment of small bowel disease.

Research perspectives
Future studies should continue to integrate the use of WCE, low risk imaging modalities and
clinical parameters in defining the best standard to identify SBI in children with CD. It will be
useful to integrate a composite of these modalities in a practical validated scoring measure that
identify SBI in the least invasive approach.

REFERENCES
1

2

3

4

5

6

7

8

9

WJG

https://www.wjgnet.com

Cuffari C, Dubinsky M, Darbari A, Sena L, Baldassano R. Crohn's jejunoileitis: the pediatrician's
perspective on diagnosis and management. Inflamm Bowel Dis 2005; 11: 696-704 [PMID: 15973125 DOI:
10.1097/01.MIB.0000166933.74477.69]
North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition; Colitis
Foundation of America, Bousvaros A, Antonioli DA, Colletti RB, Dubinsky MC, Glickman JN, Gold BD,
Griffiths AM, Jevon GP, Higuchi LM, Hyams JS, Kirschner BS, Kugathasan S, Baldassano RN, Russo
PA. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working
group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the
Crohn's and Colitis Foundation of America. J Pediatr Gastroenterol Nutr 2007; 44: 653-674 [PMID:
17460505 DOI: 10.1097/MPG.0b013e31805563f3]
Flamant M, Trang C, Maillard O, Sacher-Huvelin S, Le Rhun M, Galmiche JP, Bourreille A. The
prevalence and outcome of jejunal lesions visualized by small bowel capsule endoscopy in Crohn's
disease. Inflamm Bowel Dis 2013; 19: 1390-1396 [PMID: 23552764 DOI:
10.1097/MIB.0b013e31828133c1]
Kopylov U, Nemeth A, Koulaouzidis A, Makins R, Wild G, Afif W, Bitton A, Johansson GW, Bessissow
T, Eliakim R, Toth E, Seidman EG. Small bowel capsule endoscopy in the management of established
Crohn's disease: clinical impact, safety, and correlation with inflammatory biomarkers. Inflamm Bowel Dis
2015; 21: 93-100 [PMID: 25517597 DOI: 10.1097/MIB.0000000000000255]
Ladas SD, Triantafyllou K, Spada C, Riccioni ME, Rey JF, Niv Y, Delvaux M, de Franchis R,
Costamagna G; ESGE Clinical Guidelines Committee. European Society of Gastrointestinal Endoscopy
(ESGE): recommendations (2009) on clinical use of video capsule endoscopy to investigate small-bowel,
esophageal and colonic diseases. Endoscopy 2010; 42: 220-227 [PMID: 20195992 DOI:
10.1055/s-0029-1243968]
Levi Z, Fraser E, Krongrad R, Hazazi R, benjaminov O, meyerovitch J, Tal OB, Choen A, Niv Y, Fraser
G. Factors associated with radiation exposure in patients with inflammatory bowel disease. Aliment
Pharmacol Ther 2009; 30: 1128-1136 [PMID: 19899197 DOI: 10.1111/j.1365-2036.2009.04140.x]
Liao Z, Gao R, Xu C, Li ZS. Indications and detection, completion, and retention rates of small-bowel
capsule endoscopy: a systematic review. Gastrointest Endosc 2010; 71: 280-286 [PMID: 20152309 DOI:
10.1016/j.gie.2009.09.031]
Herrerias JM, Leighton JA, Costamagna G, Infantolino A, Eliakim R, Fischer D, Rubin DT, Manten HD,
Scapa E, Morgan DR, Bergwerk AJ, Koslowsky B, Adler SN. Agile patency system eliminates risk of
capsule retention in patients with known intestinal strictures who undergo capsule endoscopy. Gastrointest
Endosc 2008; 67: 902-909 [PMID: 18355824 DOI: 10.1016/j.gie.2007.10.063]
Aloi M, Di Nardo G, Romano G, Casciani E, Civitelli F, Oliva S, Viola F, Maccioni F, Gualdi G,
Cucchiara S. Magnetic resonance enterography, small-intestine contrast US, and capsule endoscopy to
evaluate the small bowel in pediatric Crohn's disease: a prospective, blinded, comparison study.

3820

July 28, 2019

Volume 25

Issue 28

Hijaz NM et al. Capsule endoscopy in pediatric IBD

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

29

30

WJG

https://www.wjgnet.com

Gastrointest Endosc 2015; 81: 420-427 [PMID: 25115363 DOI: 10.1016/j.gie.2014.07.009]
Pallotta N, Tomei E, Viscido A, Calabrese E, Marcheggiano A, Caprilli R, Corazziari E. Small intestine
contrast ultrasonography: an alternative to radiology in the assessment of small bowel disease. Inflamm
Bowel Dis 2005; 11: 146-153 [PMID: 15677908 DOI: 10.1097/00054725-200502000-00008]
Kovanlikaya A, Watson E, Hayward J, Beneck D, Sockolow R, Solomon A, Christos P, Brill PW.
Magnetic resonance enterography and wireless capsule endoscopy in the evaluation of patients with
inflammatory bowel disease. Clin Imaging 2013; 37: 77-82 [PMID: 23206611 DOI:
10.1016/j.clinimag.2012.03.011]
Oliva S, Cucchiara S, Civitelli F, Casciani E, Di Nardo G, Hassan C, Papoff P, Cohen SA. Colon capsule
endoscopy compared with other modalities in the evaluation of pediatric Crohn's disease of the small
bowel and colon. Gastrointest Endosc 2016; 83: 975-983 [PMID: 26363334 DOI:
10.1016/j.gie.2015.08.070]
Casciani E, Masselli G, Di Nardo G, Polettini E, Bertini L, Oliva S, Floriani I, Cucchiara S, Gualdi G. MR
enterography versus capsule endoscopy in paediatric patients with suspected Crohn's disease. Eur Radiol
2011; 21: 823-831 [PMID: 20922391 DOI: 10.1007/s00330-010-1976-3]
Albert JG, Martiny F, Krummenerl A, Stock K, Lesske J, Göbel CM, Lotterer E, Nietsch HH, Behrmann
C, Fleig WE. Diagnosis of small bowel Crohn's disease: a prospective comparison of capsule endoscopy
with magnetic resonance imaging and fluoroscopic enteroclysis. Gut 2005; 54: 1721-1727 [PMID:
16020490 DOI: 10.1136/gut.2005.069427]
Gölder SK, Schreyer AG, Endlicher E, Feuerbach S, Schölmerich J, Kullmann F, Seitz J, Rogler G,
Herfarth H. Comparison of capsule endoscopy and magnetic resonance (MR) enteroclysis in suspected
small bowel disease. Int J Colorectal Dis 2006; 21: 97-104 [PMID: 15846497 DOI:
10.1007/s00384-005-0755-0]
Tillack C, Seiderer J, Brand S, Göke B, Reiser MF, Schaefer C, Diepolder H, Ochsenkühn T, Herrmann
KA. Correlation of magnetic resonance enteroclysis (MRE) and wireless capsule endoscopy (CE) in the
diagnosis of small bowel lesions in Crohn's disease. Inflamm Bowel Dis 2008; 14: 1219-1228 [PMID:
18484672 DOI: 10.1002/ibd.20466]
Dionisio PM, Gurudu SR, Leighton JA, Leontiadis GI, Fleischer DE, Hara AK, Heigh RI, Shiff AD,
Sharma VK. Capsule endoscopy has a significantly higher diagnostic yield in patients with suspected and
established small-bowel Crohn's disease: a meta-analysis. Am J Gastroenterol 2010; 105: 1240-8; quiz
1249 [PMID: 20029412 DOI: 10.1038/ajg.2009.713]
Crook DW, Knuesel PR, Froehlich JM, Eigenmann F, Unterweger M, Beer HJ, Kubik-Huch RA.
Comparison of magnetic resonance enterography and video capsule endoscopy in evaluating small bowel
disease. Eur J Gastroenterol Hepatol 2009; 21: 54-65 [PMID: 19086147 DOI:
10.1097/MEG.0b013e32830ce7a7]
Böcker U, Dinter D, Litterer C, Hummel F, Knebel P, Franke A, Weiss C, Singer MV, Löhr JM.
Comparison of magnetic resonance imaging and video capsule enteroscopy in diagnosing small-bowel
pathology: localization-dependent diagnostic yield. Scand J Gastroenterol 2010; 45: 490-500 [PMID:
20132082 DOI: 10.3109/00365520903567817]
Jensen MD, Nathan T, Rafaelsen SR, Kjeldsen J. Diagnostic accuracy of capsule endoscopy for small
bowel Crohn's disease is superior to that of MR enterography or CT enterography. Clin Gastroenterol
Hepatol 2011; 9: 124-129 [PMID: 21056692 DOI: 10.1016/j.cgh.2010.10.019]
Wiarda BM, Mensink PB, Heine DG, Stolk M, Dees J, Hazenberg H, Stoker J, van der Woude CJ,
Kuipers EJ. Small bowel Crohn's disease: MR enteroclysis and capsule endoscopy compared to balloonassisted enteroscopy. Abdom Imaging 2012; 37: 397-403 [PMID: 22120660 DOI:
10.1007/s00261-011-9816-8]
Kopylov U, Yablecovitch D, Lahat A, Neuman S, Levhar N, Greener T, Klang E, Rozendorn N, Amitai
MM, Ben-Horin S, Eliakim R. Detection of Small Bowel Mucosal Healing and Deep Remission in Patients
With Known Small Bowel Crohn's Disease Using Biomarkers, Capsule Endoscopy, and Imaging. Am J
Gastroenterol 2015; 110: 1316-1323 [PMID: 26215531 DOI: 10.1038/ajg.2015.221]
González-Suárez B, Rodriguez S, Ricart E, Ordás I, Rimola J, Díaz-González Á, Romero C, de Miguel
CR, Jáuregui A, Araujo IK, Ramirez A, Gallego M, Fernández-Esparrach G, Ginés Á, Sendino O, Llach J,
Panés J. Comparison of Capsule Endoscopy and Magnetic Resonance Enterography for the Assessment of
Small Bowel Lesions in Crohn's Disease. Inflamm Bowel Dis 2018; 24: 775-780 [PMID: 29506048 DOI:
10.1093/ibd/izx107]
Di Nardo G, Oliva S, Ferrari F, Riccioni ME, Staiano A, Lombardi G, Costamagna G, Cucchiara S,
Stronati L. Usefulness of wireless capsule endoscopy in paediatric inflammatory bowel disease. Dig Liver
Dis 2011; 43: 220-224 [PMID: 21093392 DOI: 10.1016/j.dld.2010.10.004]
Gralnek IM, Cohen SA, Ephrath H, Napier A, Gobin T, Sherrod O, Lewis J. Small bowel capsule
endoscopy impacts diagnosis and management of pediatric inflammatory bowel disease: a prospective
study. Dig Dis Sci 2012; 57: 465-471 [PMID: 21901253 DOI: 10.1007/s10620-011-1894-5]
Gralnek IM, Defranchis R, Seidman E, Leighton JA, Legnani P, Lewis BS. Development of a capsule
endoscopy scoring index for small bowel mucosal inflammatory change. Aliment Pharmacol Ther 2008;
27: 146-154 [PMID: 17956598 DOI: 10.1111/j.1365-2036.2007.03556.x]
Bryant RV, Winer S, Travis SP, Riddell RH. Systematic review: histological remission in inflammatory
bowel disease. Is 'complete' remission the new treatment paradigm? An IOIBD initiative. J Crohns Colitis
2014; 8: 1582-1597 [PMID: 25267173 DOI: 10.1016/j.crohns.2014.08.011]
Kopylov U, Yung DE, Engel T, Vijayan S, Har-Noy O, Katz L, Oliva S, Avni T, Battat R, Eliakim R,
Ben-Horin S, Koulaouzidis A. Diagnostic yield of capsule endoscopy versus magnetic resonance
enterography and small bowel contrast ultrasound in the evaluation of small bowel Crohn's disease:
Systematic review and meta-analysis. Dig Liver Dis 2017; 49: 854-863 [PMID: 28512034 DOI:
10.1016/j.dld.2017.04.013]
Hyams J, Markowitz J, Otley A, Rosh J, Mack D, Bousvaros A, Kugathasan S, Pfefferkorn M, Tolia V,
Evans J, Treem W, Wyllie R, Rothbaum R, del Rosario J, Katz A, Mezoff A, Oliva-Hemker M, Lerer T,
Griffiths A; Pediatric Inflammatory Bowel Disease Collaborative Research Group. Evaluation of the
pediatric crohn disease activity index: a prospective multicenter experience. J Pediatr Gastroenterol Nutr
2005; 41: 416-421 [PMID: 16205508 DOI: 10.1097/01.mpg.0000183350.46795.42]
Turner D, Levine A, Walters TD, Focht G, Otley A, López VN, Koletzko S, Baldassano R, Mack D,
Hyams J, Griffiths AM. Which PCDAI Version Best Reflects Intestinal Inflammation in Pediatric Crohn
Disease? J Pediatr Gastroenterol Nutr 2017; 64: 254-260 [PMID: 27050050 DOI:
10.1097/MPG.0000000000001227]

3821

July 28, 2019

Volume 25

Issue 28

Hijaz NM et al. Capsule endoscopy in pediatric IBD
31

32

33

34

35
36

37

38

39

40

41

42

43

44

45

WJG

https://www.wjgnet.com

Abraham BP, Mehta S, El-Serag HB. Natural history of pediatric-onset inflammatory bowel disease: a
systematic review. J Clin Gastroenterol 2012; 46: 581-589 [PMID: 22772738 DOI:
10.1097/MCG.0b013e318247c32f]
Pigneur B, Seksik P, Viola S, Viala J, Beaugerie L, Girardet JP, Ruemmele FM, Cosnes J. Natural history
of Crohn's disease: comparison between childhood- and adult-onset disease. Inflamm Bowel Dis 2010; 16:
953-961 [PMID: 19834970 DOI: 10.1002/ibd.21152]
de Bie CI, Paerregaard A, Kolacek S, Ruemmele FM, Koletzko S, Fell JM, Escher JC, EUROKIDS Porto
IBD Working Group of ESPGHAN. Disease phenotype at diagnosis in pediatric Crohn's disease: 5-year
analyses of the EUROKIDS Registry. Inflamm Bowel Dis 2013; 19: 378-385 [PMID: 22573581 DOI:
10.1002/ibd.23008]
Kim OZ, Han DS, Park CH, Eun CS, Kim YS, Kim YH, Cheon JH, Ye BD, Kim JS. The Clinical
Characteristics and Prognosis of Crohn's Disease in Korean Patients Showing Proximal Small Bowel
Involvement: Results from the CONNECT Study. Gut Liver 2018; 12: 67-72 [PMID: 28798284 DOI:
10.5009/gnl16500]
Freeman HJ. Natural history and long-term clinical course of Crohn's disease. World J Gastroenterol
2014; 20: 31-36 [PMID: 24415855 DOI: 10.3748/wjg.v20.i1.31]
Keh C, Shatari T, Yamamoto T, Menon A, Clark MA, Keighley MR. Jejunal Crohn's disease is associated
with a higher postoperative recurrence rate than ileocaecal Crohn's disease. Colorectal Dis 2005; 7: 366368 [PMID: 15932560 DOI: 10.1111/j.1463-1318.2005.00766.x]
Mao R, Tang RH, Qiu Y, Chen BL, Guo J, Zhang SH, Li XH, Feng R, He Y, Li ZP, Zeng ZR, Eliakim R,
Ben-Horin S, Chen MH. Different clinical outcomes in Crohn's disease patients with
esophagogastroduodenal, jejunal, and proximal ileal disease involvement: is L4 truly a single phenotype?
Therap Adv Gastroenterol 2018; 11: 1756284818777938 [PMID: 29899757 DOI:
10.1177/1756284818777938]
Lazarev M, Huang C, Bitton A, Cho JH, Duerr RH, McGovern DP, Proctor DD, Regueiro M, Rioux JD,
Schumm PP, Taylor KD, Silverberg MS, Steinhart AH, Hutfless S, Brant SR. Relationship between
proximal Crohn's disease location and disease behavior and surgery: a cross-sectional study of the IBD
Genetics Consortium. Am J Gastroenterol 2013; 108: 106-112 [PMID: 23229423 DOI:
10.1038/ajg.2012.389]
Van Limbergen J, Russell RK, Drummond HE, Aldhous MC, Round NK, Nimmo ER, Smith L, Gillett
PM, McGrogan P, Weaver LT, Bisset WM, Mahdi G, Arnott ID, Satsangi J, Wilson DC. Definition of
phenotypic characteristics of childhood-onset inflammatory bowel disease. Gastroenterology 2008; 135:
1114-1122 [PMID: 18725221 DOI: 10.1053/j.gastro.2008.06.081]
Giles E, Barclay AR, Chippington S, Wilson DC. Systematic review: MRI enterography for assessment of
small bowel involvement in paediatric Crohn's disease. Aliment Pharmacol Ther 2013; 37: 1121-1131
[PMID: 23638954 DOI: 10.1111/apt.12323]
Klang E, Amitai MM, Lahat A, Yablecovitch D, Avidan B, Neuman S, Levhar N, Rozendorn N, Weiss B,
Ben-Horin S, Eliakim R, Kopylov U, Israeli IBD research Nucleus [IIRN). Capsule Endoscopy Validation
of the Magnetic Enterography Global Score in Patients with Established Crohn's Disease. J Crohns Colitis
2018; 12: 313-320 [PMID: 29182750 DOI: 10.1093/ecco-jcc/jjx156]
Klang E, Kopylov U, Eliakim R, Rozendorn N, Yablecovitch D, Lahat A, Ben-Horin S, Amitai MM.
Diffusion-weighted imaging in quiescent Crohn's disease: correlation with inflammatory biomarkers and
video capsule endoscopy. Clin Radiol 2017; 72: 798.e7-798.e13 [PMID: 28506799 DOI:
10.1016/j.crad.2017.04.006]
Kopylov U, Yung DE, Engel T, Avni T, Battat R, Ben-Horin S, Plevris JN, Eliakim R, Koulaouzidis A.
Fecal calprotectin for the prediction of small-bowel Crohn's disease by capsule endoscopy: a systematic
review and meta-analysis. Eur J Gastroenterol Hepatol 2016; 28: 1137-1144 [PMID: 27415156 DOI:
10.1097/MEG.0000000000000692]
Kopylov U, Klang E, Yablecovitch D, Lahat A, Avidan B, Neuman S, Levhar N, Greener T, Rozendorn
N, Beytelman A, Yanai H, Dotan I, Chowers Y, Weiss B, Ben-Horin S, Amitai MM, Eliakim R; Israeli
IBD research Nucleus (IIRN). Magnetic resonance enterography versus capsule endoscopy activity indices
for quantification of small bowel inflammation in Crohn's disease. Therap Adv Gastroenterol 2016; 9:
655-663 [PMID: 27582877 DOI: 10.1177/1756283X16649143]
Mergener K, Ponchon T, Gralnek I, Pennazio M, Gay G, Selby W, Seidman EG, Cellier C, Murray J, de
Franchis R, Rösch T, Lewis BS. Literature review and recommendations for clinical application of smallbowel capsule endoscopy, based on a panel discussion by international experts. Consensus statements for
small-bowel capsule endoscopy, 2006/2007. Endoscopy 2007; 39: 895-909 [PMID: 17968807 DOI:
10.1055/s-2007-966930]

3822

July 28, 2019

Volume 25

Issue 28

Published By Baishideng Publishing Group Inc
7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Telephone: +1-925-2238242
Fax: +1-925-2238243
E-mail: bpgoffice@wjgnet.com
Help Desk:http://www.f6publishing.com/helpdesk
http://www.wjgnet.com

© 2019 Baishideng Publishing Group Inc. All rights reserved.

